跳转至内容
Merck
CN
  • Effects of citraconylation on enzymatic modification of human proinsulin using trypsin and carboxypeptidase B.

Effects of citraconylation on enzymatic modification of human proinsulin using trypsin and carboxypeptidase B.

Biotechnology progress (2009-07-03)
Young-Jin Son, Chang-Kyu Kim, Young Bong Kim, Dae-Hyuk Kweon, Yong-Cheol Park, Jin-Ho Seo
摘要

Insulin is a polypeptide hormone which is produced by the beta-cell of pancreas and controls the blood glucose level in the human body. Enzymatic modification of human proinsulin using trypsin and carboxypeptidase B generally causes high accumulation of insulin derivatives, leading to more complicated purification processes. A simple method including citraconylation and decitraconylation in the enzymatic modification process was developed for the reduction of a major derivative, des-threonine human insulin. Addition of 3.0 g citraconic anhydride per g protein into the reaction solution led to the citraconylation of lysine residues in human proinsulin and reduction of relative des-threonine insulin content from 13.5 to 1.0%. After the enzymatic hydrolysis of the citraconylated proinsulin, 100% of lysine residues can be decitraconylated and restored by adjusting pH to 2-3 at 25 degrees C. Combination of hydrogen peroxide addition and citraconylation of proinsulin expressed in recombinant Escherichia coli remarkably improved the conversion yield of insulin from 52.7 to 77.7%. Consequently, citraconylation of lysine residues blocked the unexpected cleavage of human proinsulin by trypsin, minimized the formation of des-threonine insulin and hence increased the production yield of active insulin.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
羧肽酶 B 来源于猪胰腺, lyophilized powder
Sigma-Aldrich
柠康酸酐, 98%
Sigma-Aldrich
羧肽酶 B 来源于人类胰腺, 50-55 units/mg protein carboxypeptidase B